INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 411m ago
HOUSE PTR11m ago
SEC 13F11m ago
ROBINHOOD CHAIN11m ago
SEC FORM 4/Grant or awardVerified data

Wesolowski John M reported INTS

Principal Accounting Officer · INTENSITY THERAPEUTICS, INC. · Common Stock, $0.0001 Par Value

Side
A
Value
$13K
Shares
3,688
Price
$3.49
Executed
Jun 30, 2026
Disclosed
Jul 1, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 30 executedJul 1, 2026 disclosed

INTS · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+13 / 25

$13K reported value · 108.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · INTS

    No records

    No other disclosures for this security in the dataset.

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001895944-26-000006
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jun 30, 2026
    Published
    Jul 1, 2026
    Ingested by INSIDER
    Nov 5, 03:50 UTC
    Last re-read
    Nov 5, 03:50 UTC

    Extracted facts

    Filer
    Wesolowski John M
    Role
    Principal Accounting Officer
    Transaction
    Grant or awardAs filed: “A”
    Asset
    INTENSITY THERAPEUTICS, INC.
    Ticker
    INTS
    Shares
    3,688
    Price per share
    $3.49
    Value
    $12,853
    Execution date (reported)
    Jun 30, 2026
    Owned after transaction
    7,102 shares
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 3,688
    • Price: $3.485

    = $12,853

    What this establishes

    Wesolowski John M filed this Form 4 reporting a grant or award of INTS on Jun 30, 2026. It became public on Jul 1, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Principal Accounting Officer
    Wesolowski John Mcik:0001895944
    Issuer
    INTENSITY THERAPEUTICS, INC.cik:0001567264

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.